In this sense, disruption of the RNF43–ZNRF3 axis in the serrated pathway may serve similar, but not identical, functions to the APC mutations do in the adenoma–carcinoma pathway, which may have implications for the therapeutic targeting of the Wnt pathway in different CRC subtypes. This evidence concerns the gene ZNRF3 and colorectal carcinoma.